Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

thelancet.com

The Lancet

Get the latest updates from The Lancet directly as they happen.

Follow now 129 followers

Latest posts

Last updated 6 days ago

Lenacapavir approved for HIV but draws ire over cost

6 days ago

Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks...

Population health impact of NICE-recommended new drugs

6 days ago

The conclusion from Huseyin Naci and colleagues1 that more quality-adjusted life-years (QALYs)...

Assisted dying bill advances in the House of Commons

6 days ago

The House of Commons has approved the Terminally Ill Adults Bill amid...

US Supreme Court upholds Tennessee law denying adolescents gender-affirming care

6 days ago

Conservative justices agreed with the state and Trump administration that banning minors’...

Population health impact of NICE-recommended new drugs – Authors' reply

6 days ago

We appreciate the responses to our Article,1 which suggest that the health...

Early-onset type 2 diabetes: the next major diabetes transition

10 days ago

The incidence of early-onset type 2 diabetes is increasing, with a growing...

Understanding the drivers and consequences of early-onset type 2 diabetes

10 days ago

Early-onset type 2 diabetes (defined as type 2 diabetes diagnosed in people...

Managing early-onset type 2 diabetes in the individual and at the population level

10 days ago

Early-onset type 2 diabetes (defined as type 2 diabetes diagnosed in people...

Early-onset type 2 diabetes: no time for defeatism

10 days ago

Considered a disease of middle-aged and older adults until the late 20th...

Future of once-weekly insulins in type 2 diabetes: efficacy and safety

11 days ago

Type 2 diabetes is characterised by insulin resistance and progressive β-cell decline...